VIMMRYXTO Trademark 98294740 - Trademark Alertz

Trademark: 98294740

Word

VIMMRYXTO

Status

Pending

Status Code

681

Status Date

Monday, September 23, 2024

Serial Number

98294740

Mark Type

Filing Date

Friday, December 1, 2023

Published for Opposition

Tuesday, October 29, 2024

Trademark Owner History

GlaxoSmithKline Biologicals SA

Classifications

5 Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events

Dec 1, 2023

New Application Entered

Feb 25, 2024

New Application Office Supplied Data Entered

Jun 29, 2024

Suspension Letter Written

Jun 29, 2024

Letter Of Suspension E-Mailed

Sep 12, 2024

Correspondence Received In Law Office

Sep 12, 2024

Teas/Email Correspondence Entered

Sep 12, 2024

Teas Response To Suspension Inquiry Received

Sep 13, 2024

Approved For Pub - Principal Register

Jun 29, 2024

Assigned To Examiner

Jun 29, 2024

Notification Of Letter Of Suspension E-Mailed

Sep 19, 2024

On Hold - Electronic Record Review Required

ANTATX

PERI

Trademark Alertz updated from USPTO on 2030-01-24